MAGE-A3 regulates tumor stemness in gastric cancer through the PI3K/AKT pathway

• Published in: Aging (Albany, NY.) Vol. 14; no. 23; pp. 9579 - 9598
• Main Authors: Yu, Qi-Ying, Wang, Zhi-Wen, Zhou, Meng-Ying, Li, Shang-Fu, Liao, Xing-Hua
• Format: Journal Article
• Language: English
• Published: United States Impact Journals 08.11.2022
• Subjects: Antigens, Neoplasm - genetics; Humans; Neoplastic Stem Cells; Phosphatidylinositol 3-Kinases - genetics; Prognosis; Proto-Oncogene Proteins c-akt - genetics; Research Paper; Stomach Neoplasms - genetics; Stomach Neoplasms - pathology; gastric cancer; WGCNA; mRNAsi; MAGE-A3
• ISSN: 1945-4589; 1945-4589
• DOI: 10.18632/aging.204373

Gastric cancer remains a malignant disease of the digestive tract with high mortality and morbidity worldwide. However, due to its complex pathological mechanisms and lack of effective clinical therapies, the survival rate of patients after receiving treatment is not satisfactory. A increasing number of studies have focused on cancer stem cells and their regulatory properties. In this study, we first constructed a co-expression network based on the WGCNA algorithm to identify modules with different degrees of association with tumor stemness indices. After selecting the most positively correlated modules of the stemness index, we performed a consensus clustering analysis on gastric cancer samples and constructed the co-expression network again. We then selected the modules of interest and applied univariate COX regression analysis to the genes in this module for preliminary screening. The results of the screening were then used in LASSO regression analysis to construct a risk prognostic model and subsequently a sixteen-gene model was obtained. Finally, after verifying the accuracy of the module and screening for risk genes, we identified MAGE-A3 as the final study subject. We then performed and experiments to verify its effect on tumor stemness and tumour proliferation. Our data supports that MAGE-A3 is a tumor stemness regulator and a potent prognostic biomarker which can help the prediction and treatment of gastric cancer patients.